About Ultratech India
Ultratech India is a Healthcare company based in Vashi (India) founded in 1992 by Rishi Bhatia. It manufactures pharmaceutical finished dosage forms, APIs, drug intermediates, and offers custom research services. It operates on a B2B and D2C model. The company has 50 employees. Its chief executive, as recorded, is Rishi Bhatia. Its Indian entity Ultratech India Limited reported revenue of ₹50.24 Cr. Ultratech India offers products and services including Finished Dosage Forms, Active Pharmaceutical Ingredients, Drug Intermediates, Women’s Healthcare Products, and CRAMS Services. Its focus areas include Pharmaceuticals, Research Services, CRAMS and Drug Manufacturing. Its competitors include BDR Pharmaceuticals Internationals and Aurobindo Pharma; 1 of its 2 listed competitors has raised funding.
Company details
Ultratech India Limited is a pharmaceutical company based in Navi Mumbai, India, focused on manufacturing finished dosage forms like inhalers and APIs for various therapies. They specialize in pulmonary drug delivery systems and provide custom research and manufacturing services, including contract work for drug intermediates and womens healthcare products, serving the global healthcare industry through innovative development and production.
- Headquarters Vashi, India
- Employees 50
- Founders Rishi Bhatia
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ultratechindia.com
- Legal Name Ultratech India Limited
- Date of Incorporation 20 Jul, 1992
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹50.24 Cr
FY 2025 · +84% YoY
- Net Profit₹5.11 Cr
FY 2025 · 10% margin
- EBITDA₹10.60 Cr
FY 2025 · 21% margin
- Employee Count50
Associated legal entities of Ultratech India
Ultratech India operates through Ultratech India Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ultratech India Limited CIN U24110MH1992PLC067786 | Active | 20 Jul 1992 | Navi Mumbai, Maharashtra | ₹50.2 Cr | 50 | 7 | View details |
Products & Services of Ultratech India
Ultratech India offers a comprehensive portfolio of products and services, including Finished Dosage Forms, Active Pharmaceutical Ingredients, Drug Intermediates, Women’s Healthcare Products, and CRAMS Services.
Inhalers and tablets for drug delivery in respiratory care.
APIs for treatments in cardiovascular and antiviral fields.
Advanced intermediates for pharmaceutical synthesis processes.
Natural products for vaginal tightening and rejuvenation.
Custom synthesis and manufacturing for pharmaceutical formulations.
Board of directors of Ultratech India Limited (Ultratech India)
Ultratech India Limited is the primary company behind Ultratech India. The board of Ultratech India Limited currently have 5 directors; the longest-serving is Rishi Vedprakash Bhatia, appointed in 1992. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rishi Vedprakash Bhatia DIN 00281820 | Managing Director | 22 Jul 1992 | 34 yrs 3 mo | Ultratech India Limited |
| Meena Bhatia DIN 00281929 | Director | 01 Mar 2011 | 15 yrs 8 mo | Ultratech India Limited |
| Ramnaresh Rajkumar Agrawal DIN 07719739 | Director | 01 Aug 2017 | 9 yrs 3 mo | Ultratech India Limited |
| Manoj Yadneshwar Thakur DIN 08833618 | Director | 27 Aug 2020 | 6 yrs 2 mo | Ultratech India Limited |
| Shashank Dilip Meshram DIN 07677426 | Director | 29 Jun 2024 | 2 yrs 4 mo | Ultratech India Limited |
People of Ultratech India
1 people are tracked at Ultratech India (1 in leadership); the tracked headcount is 50.
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership |
Complete people profiles for Ultratech India
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Ultratech India
Figures of Ultratech India Limited, the primary company behind Ultratech India, for FY 2025. Revenue was ₹50.24 Cr (+84% year on year). Net profit was ₹5.11 Cr (10% margin). EBITDA was ₹10.60 Cr (21% margin). Revenue has grown at a compounded annual rate of +31% over three years and +5% over five years.
- ₹50.24 CrRevenue · FY 2025 · +84% YoY
- ₹5.11 CrNet profit · 10% margin
- ₹10.60 CrEBITDA · 21% margin
- ₹11.98 CrPaid-up capital
- 50Employees (provident fund records)
- +31%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ultratech India Limited are on its company page.
Detailed financial statements for Ultratech India
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Ultratech India
Ultratech India has 2 listed competitors in our database, 1 of them funded. They include BDR Pharmaceuticals Internationals and Aurobindo Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. | |
| aurobindo.com | 1986 | Hyderabad, India | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. |
Detailed competitors of Ultratech India
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ultratech India
The website of Ultratech India (ultratechindia.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 11.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ultratech India
Ultratech India was founded in 1992.
Ultratech India is headquartered in Vashi, India. It is registered at Vashi, Maharashtra, India.
Rishi Bhatia is the CEO of Ultratech India, as recorded in our data. They have also founded this company.
Ultratech India has 50 employees.
The primary company behind Ultratech India, Ultratech India Limited, reported revenue of ₹50.24 Cr for FY 2025, up 84% year on year.
Ultratech India Limited is a pharmaceutical company based in Navi Mumbai, India, focused on manufacturing finished dosage forms like inhalers and APIs for various therapies. They specialize in pulmonary drug delivery systems and provide custom research and manufacturing services, including contract work for drug intermediates and womens healthcare products, serving the global healthcare industry through innovative development and production.
Ultratech India's top competitors include BDR Pharmaceuticals Internationals and Aurobindo Pharma.
Ultratech India offers Finished Dosage Forms, Active Pharmaceutical Ingredients, Drug Intermediates, Women’s Healthcare Products, and CRAMS Services.
Ultratech India operates through Ultratech India Limited.
The legal entities of Ultratech India currently have 6 directors, including Shashank Dilip Meshram, Manoj Yadneshwar Thakur, Ramnaresh Rajkumar Agrawal and others.